<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "temsirolimus inj VIAL">
<dose><value>25</value>
<value>20</value>
<value>15</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>temsirolimus inj VIAL</value>
</drugname><strength><value>25 mg/mL</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Administer dose over 30 minutes, diluted in 250 mL 0.9% sodium chloride.</value>
<value>Administer dose over 60 minutes, diluted in 250 mL 0.9% sodium chloride.</value>
</instruction><volume><value>1.2 mL</value>
</volume><units><value>mg</value>
</units><additionalnotes><value>Metastatic Renal Cell Carcinoma. Dose reduction levels level (-1) 20 mg, level (-2) 15 mg. Temsirolimus is contraindicated in patients with bilirubin levels greater than 1.5 times ULN.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3624</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose></maximumprndose><din><value>02304104</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>